Findings from the REC-CAGEFREE trial presented at the 2024 European Society of Cardiology (ESC) Congress suggest that drug-coated balloon angioplasty is less effective in addressing previously untreated non-complex coronary lesions when compared to second generation drug eluting stents (DES).